Search Results Search Sort by RelevanceMost Recent History of Medicine May 2010 Advertising Cosmetic Surgery Deborah A. Sullivan, PhD The use of advertisements for cosmetic surgery has fluctuated throughout the twentieth century. Virtual Mentor. 2010;12(5):407-411. doi: 10.1001/virtualmentor.2010.12.5.mhst1-1005. Podcast May 2010 Ethics Talk: Cosmetic Surgery - Is it Cheating? Our Society's Mixed Views about Cosmetic Surgery Virtual Mentor asked six "people on the street" in Chicago for their views about the personal and social effects of elective cosmetic surgery. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Medical Education Jun 2003 Grutter v Bollinger Susanna Smith This article gives a brief overview of two legal cases where students were denied admission to the University of Michigan. Virtual Mentor. 2003;5(6):208-210. doi: 10.1001/virtualmentor.2003.5.6.medu1-0306. In the Literature Jun 2003 Assessing Affirmative Action in Medical Schools Michelle Lim The president of the Association of American Medical Colleges gives reasons why medical schools need to continue affirmative action admissions policies. Virtual Mentor. 2003;5(6):219-221. doi: 10.1001/virtualmentor.2003.5.6.jdsc3-0306. Policy Forum Jun 2003 Diversity and the Road to the "Land of Best Care" Lonnie R. Bristow, MD The author discusses why the U.S. needs ethnically diverse medical professionals in order to stay competitive in the global economy. Virtual Mentor. 2003;5(6):225-227. doi: 10.1001/virtualmentor.2003.5.6.pfor1-0306. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Next page Next › Last page Last »
History of Medicine May 2010 Advertising Cosmetic Surgery Deborah A. Sullivan, PhD The use of advertisements for cosmetic surgery has fluctuated throughout the twentieth century. Virtual Mentor. 2010;12(5):407-411. doi: 10.1001/virtualmentor.2010.12.5.mhst1-1005.
Podcast May 2010 Ethics Talk: Cosmetic Surgery - Is it Cheating? Our Society's Mixed Views about Cosmetic Surgery Virtual Mentor asked six "people on the street" in Chicago for their views about the personal and social effects of elective cosmetic surgery.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Medical Education Jun 2003 Grutter v Bollinger Susanna Smith This article gives a brief overview of two legal cases where students were denied admission to the University of Michigan. Virtual Mentor. 2003;5(6):208-210. doi: 10.1001/virtualmentor.2003.5.6.medu1-0306.
In the Literature Jun 2003 Assessing Affirmative Action in Medical Schools Michelle Lim The president of the Association of American Medical Colleges gives reasons why medical schools need to continue affirmative action admissions policies. Virtual Mentor. 2003;5(6):219-221. doi: 10.1001/virtualmentor.2003.5.6.jdsc3-0306.
Policy Forum Jun 2003 Diversity and the Road to the "Land of Best Care" Lonnie R. Bristow, MD The author discusses why the U.S. needs ethnically diverse medical professionals in order to stay competitive in the global economy. Virtual Mentor. 2003;5(6):225-227. doi: 10.1001/virtualmentor.2003.5.6.pfor1-0306.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.